Helius Price Sales Ratio from 2010 to 2025

HSDT Stock  USD 0.41  0  0.98%   
Helius Medical Price Sales Ratio yearly trend continues to be comparatively stable with very little volatility. Price Sales Ratio will likely drop to 33.18 in 2025. From the period from 2010 to 2025, Helius Medical Price Sales Ratio quarterly data regression had r-value of (0.86) and coefficient of variation of  83.66. View All Fundamentals
 
Price Sales Ratio  
First Reported
2010-12-31
Previous Quarter
34.93011931
Current Value
33.18
Quarterly Volatility
213.11946138
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius Medical's main balance sheet or income statement drivers, such as Interest Expense of 280.8 K, Selling General Administrative of 9.6 M or Other Operating Expenses of 16.1 M, as well as many indicators such as Price To Sales Ratio of 33.18, Dividend Yield of 0.0 or PTB Ratio of 18.01. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.
  
Check out the analysis of Helius Medical Correlation against competitors.

Latest Helius Medical's Price Sales Ratio Growth Pattern

Below is the plot of the Price Sales Ratio of Helius Medical Technologies over the last few years. It is Helius Medical's Price Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Helius Medical's overall financial position and show how it may be relating to other accounts over time.
Price Sales Ratio10 Years Trend
Slightly volatile
   Price Sales Ratio   
       Timeline  

Helius Price Sales Ratio Regression Statistics

Arithmetic Mean254.76
Geometric Mean106.32
Coefficient Of Variation83.66
Mean Deviation204.61
Median436.63
Standard Deviation213.12
Sample Variance45,420
Range431
R-Value(0.86)
Mean Square Error12,932
R-Squared0.73
Significance0.000022
Slope(38.36)
Total Sum of Squares681,299

Helius Price Sales Ratio History

2025 33.18
2024 34.93
2023 7.59
2022 5.27
2021 24.43
2020 23.91
2019 17.09

About Helius Medical Financial Statements

Helius Medical shareholders use historical fundamental indicators, such as Price Sales Ratio, to determine how well the company is positioned to perform in the future. Although Helius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Helius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Price Sales Ratio 34.93  33.18 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.